AML-897: Treatment Intensity Does Not Affect Survival in TP53-Mutated Acute Myeloid Leukemia: Real-World Outcomes From a Racially Diverse Academic Center
Year: 2026
Type: conference-abstract
Institution: Baylor College of Medicine
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: treatment intensity, intensive chemotherapy, low-intensity chemotherapy, overall survival, progression-free survival, complete remission, 7+3 induction, venetoclax, hypomethylating agents, racial diversity, Black patients, Hispanic patients, comorbidities, adverse-risk AML, real-world outcomes, chemoresistance
Open Access status: closed
OpenAlex ID: W7204705127
